BSAC Spring Conference & AGM
Addressing the AMR burden in everyday practice
18-19 May 2023
QEII Conference Centre London & online
Welcome to the BSAC Spring Conference
Welcome to the BSAC Spring Conference & AGM 2023: Addressing the AMR burden in everyday practice
You can view the recorded content from this hybrid conference.
Abstracts from this conference are now published and available to view open access here.
This conference is RCPath CPD accredited.
Programme
Welcome and opening remarks
Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC PresidentManagement of imported infections - CPE from Ukranian casualties treated in The Netherlands
Dr Daan Notermans, Medical Microbiologist, Dutch National Institute for Public Health and the Environment (RIVM)Tuberculosis - programmatic testing and treatment for latent tuberculosis in migrants
Professor Ajit Lalvani, NIHR Health Protection Research Unit in Respiratory Infections, Imperial College LondonGroup A streptococcus pleural empyema in children
Dr Thomas Christie Williams, Wellcome Trust ECAT Clinical Lecturer, The University of Edinburgh & Registrar in Respiratory Paediatrics at the Royal Hospital for Children, GlasgowQ&A
Balancing the opportunity and risk: the political importance of making this happen
Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social CareDeath certification and AMR
Dr Alan Fletcher, National Medical Examiner for England and WalesWhat education, training and advocacy is now needed?
Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC PresidentPanel discussion
New models of antimicrobial funding in England
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSACUKAR update
Professor Gareth Jones, Professor in Epidemiology at the University of Aberdeen and Co-Chief Investigator of the UK Antimicrobial RegistryQ&A
Systemic fungal infections - the stewardship challenges
Ms Laura Whitney, Regional Antimicrobial Stewardship Lead London, NHS England and NHS ImprovementImplementation of an antifungal stewardship program and the impact on a stem cell transplant centre
Mr Richard Wilson, Research Pharmacist, Imperial College LondonCandida resistance in the ICU
Dr Tihana Bicanic, Reader & Consultant in Infectious Diseases, St George’s University of London & St George’s HospitalQ&A
Rethinking AMS: New ideas for appropriate access from India
Dr Ramanan Laxminarayan, President of the One Health Trust, Senior Research Scholar, Princeton UniversityQ&A
Understanding the role of accessory genes in AMR phenotype using interpretable machine learning models.
Miss Lucy Dillon, PhD Student, Queen's University BelfastThe consumption of human antibiotics in veterinary medicine, in Estonia, 2006–2022
Mrs Marju Sammul, PhD Student, Estonian University of Life SciencesPatterns of general practitioner and nurse independent prescriber prescriptions for antibiotics dispensed in the community in England: A retrospective analysis
Professor Molly Courtenay, Cardiff UniversityPenicillin and cephalosporin cross-reactivity; a single centre UK study
Miss Eve Duke, Pharmacist, Leeds Teaching Hospitals TrustHow do we translate policy to practice in the UK
Dr Louise Savic, Leeds Teaching HospitalsPenfast study - lessons from Australia
Associate Professor Jason Trubiano, Infectious Diseases Physician & NHMRC Early Career Researcher, University of Melbourne, Department of Medicine (Austin Health)Q&A
Nothing changes unless it changes: The role of rapid diagnostics in hepatology
Dr Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver ResearchQ&A
The post treatment impact of antimicrobials in the environment – a threat to yet be understood?
Professor Will Gaze, University of ExeterAchieving sustainable antimicrobial usage: exploring the “how” from a systems perspective
Dr Kelly Thornber, Research Fellow, University of ExeterConfronting a Permacrisis - the intersection between antimicrobial resistance, climate change and biodiversity loss
Mr Tom Tayler, Aviva InvestorsQ&A
Phage therapy
Professor Martha Clokie, Professor of Microbiology, University of LeicesterLarge scale cohort studies and genomics to understand Staphylococcus aureus colonisation and biology
Dr Ewan Harrison, Wellcome Sanger InstituteFaecal transplants
Professor Mark Wilcox, Leeds Teaching Hospitals NHS TrustDo it simple, do it well: reducing infection through low cost preventative measures
Professor Tim Walsh, University of OxfordQ&A
The AMR Narrative
Ms Vanessa Carter, AMR Patient Survivor & One Health Advocate and Founder, The AMR NarrativeQ&A
© 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118